These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15807367)

  • 1. The demise of Bayh-Dole protections against the Pharmaceutical Industry's abuses of government-funded inventions.
    Schofield AR
    J Law Med Ethics; 2004; 32(4):777-83. PubMed ID: 15807367
    [No Abstract]   [Full Text] [Related]  

  • 2. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents.
    Malakoff D
    Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775
    [No Abstract]   [Full Text] [Related]  

  • 3. The Bayh-Dole Act, a lion without claws.
    Feldman AM
    Clin Transl Sci; 2015 Feb; 8(1):3-4. PubMed ID: 25675969
    [No Abstract]   [Full Text] [Related]  

  • 4. March-in rights under the Bayh-Dole Act: the NIH's paper tiger?
    O'Brien W
    Seton Hall Law Rev; 2013 Nov; 43(4):1403-32. PubMed ID: 24308083
    [No Abstract]   [Full Text] [Related]  

  • 5. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir.
    Huff B
    GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438
    [No Abstract]   [Full Text] [Related]  

  • 6. Access to drugs: the case of Abbott in Thailand.
    Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S
    Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589
    [No Abstract]   [Full Text] [Related]  

  • 7. NIH denies march-in rights on Norvir patent.
    Harrison C
    Nat Rev Drug Discov; 2013 Dec; 12(12):898. PubMed ID: 24287772
    [No Abstract]   [Full Text] [Related]  

  • 8. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backlash over ritonavir price hike.
    Huff B
    BETA; 2004; 16(4):15-7. PubMed ID: 15386839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent medicine.
    Baker D
    J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309
    [No Abstract]   [Full Text] [Related]  

  • 11. The Bayh-Dole Act: a model for promoting research translation?
    Loewenberg S
    Mol Oncol; 2009 Apr; 3(2):91-3. PubMed ID: 19383372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bayh-Dole Act turns 30.
    Loise V; Stevens AJ
    Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the public's right to access medical discoveries based on federally funded research?
    Treasure CL; Avorn J; Kesselheim AS
    JAMA; 2014 Mar; 311(9):907-8. PubMed ID: 24595771
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from Bayh-Dole.
    Sampat BN
    Nature; 2010 Dec; 468(7325):755-6. PubMed ID: 21150971
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 16. The antibiotic pipeline.
    Kunin CM
    N Engl J Med; 2004 Nov; 351(19):2019-20. PubMed ID: 15525731
    [No Abstract]   [Full Text] [Related]  

  • 17. Use the Bayh-Dole Act to lower drug prices for government healthcare programs.
    Engelberg AB; Kesselheim AS
    Nat Med; 2016 Jun; 22(6):576. PubMed ID: 27270771
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking the profit out of biomedical research tools.
    Flores MA
    Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical industry must take its medicine.
    Macilwain C
    Nature; 2011 Feb; 470(7333):141. PubMed ID: 21307893
    [No Abstract]   [Full Text] [Related]  

  • 20. Patents and innovation in cancer therapeutics: lessons from CellPro.
    Bar-Shalom A; Cook-Deegan R
    Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.